Today: 7 November 2025
Subscribe
Expedia Group (EXPE) soars on Q3 2025 beat and higher full‑year outlook; B2B bookings power rally — Nov. 7, 2025
 ·  ·  ·  ·  · 

Expedia Group (EXPE) soars on Q3 2025 beat and higher full‑year outlook; B2B bookings power rally — Nov. 7, 2025

by
7 November 2025

Expedia Group, Inc. (NASDAQ: EXPE) reported stronger‑than‑expected third‑quarter results after the bell on Nov. 6 and raised its 2025 guidance. Shares jumped as much as ~16% in pre‑market trading today (Nov. 7) as investors cheered accelerating B2B momentum and margin expansion. [1]

Key takeaways

  • Q3 2025 topped guidance: Revenue $4.41B (+9% y/y); gross bookings $30.73B (+12%); adjusted EBITDA $1.45B (+16%; ~33% margin); adjusted EPS $7.57 (+23%). Room nights 108.2M (+11%). [2]
  • B2B strength: B2B gross bookings rose 26% y/y and B2B revenue grew 18%, continuing a multi‑quarter streak of double‑digit growth. Advertising revenue grew 16%. [3]
  • Guidance raised: For FY 2025, Expedia now sees revenue up 6%–8% and gross bookings up 6%–8%, with ~2 percentage points of adjusted EBITDA margin expansion (prior outlook: ~1 point). For Q4 2025, management guides to ~7% gross bookings growth and 6%–7% revenue growth. [4]
  • Capital returns: Expedia repurchased $451M of stock in Q3 and declared a $0.40 quarterly dividend payable Dec. 11, 2025 (record date Nov. 19, 2025). [5]
  • Market reaction: Shares spiked in early trade on the outlook boost and continued B2B gains, with analysts highlighting the cleaner path to margin expansion. [6]

What happened

Expedia said demand accelerated into the September quarter, with U.S. room‑nights growing at the fastest pace in over three years while international momentum remained solid. CEO Ariane Gorin pointed to reinforcing effects of its two‑sided marketplace and execution against strategic priorities as drivers of the outperformance. [7]

The company’s B2B platform—powering partners like travel agencies, banks and offline sellers—again led the way: B2B bookings +26% y/y and B2B revenue +18%. That mix shift, coupled with expense discipline, lifted adjusted EBITDA margin by ~208 bps to roughly 33% in Q3. Advertising also provided a tailwind, up 16% year over year. [8]

By the numbers (Q3 2025)

  • Gross bookings:$30.73B (+12% y/y)
  • Revenue:$4.41B (+9%)
  • Adjusted EBITDA:$1.45B (+16%); ~32.9% margin
  • Adjusted EPS:$7.57 (+23%)
  • Room nights:108.2M (+11%)
  • Share repurchases:$451M in Q3
  • Dividend:$0.40 per share declared Nov. 6; payable Dec. 11, 2025
    These figures come from Expedia’s earnings materials and investor update. [9]

2025 outlook: raised across the board

Management lifted full‑year guidance to 6%–8% revenue growth and 6%–8% gross bookings growth, and now expects ~2 points of adjusted EBITDA margin expansion for 2025 (previously ~1 point). For the holiday quarter (Q4 2025), Expedia targets ~7% gross bookings growth and 6%–7% revenue growth. [10]

External reporting echoed the stronger setup, with pre‑market gains of about 15%–16% as investors focused on the higher margin outlook and B2B traction. Reuters also highlighted that Asia room‑nights climbed 20%+, while U.S. growth showed share gains amid more price‑sensitive travelers. [11]

Street reaction today (Nov. 7, 2025)

  • Piper Sandler upgraded EXPE to Neutral from Underweight and raised its price target to $250 following the print. [12]
  • RBC Capitallifted its target to $260; other firms raised targets as well, citing accelerating bookings and operating leverage. [13]
  • Coverage also noted that Expedia’s partnerships and AI roadmap help calm disruption fears while preserving marketing efficiency. [14]

Why it matters

  • Mix shift to B2B: B2B continues to outgrow consumer travel, providing steadier, higher‑visibility revenue and cushioning against consumer cyclicality. [15]
  • Margin credibility: The step‑up from ~1 point to ~2 points of expected margin expansion for 2025 suggests Expedia’s re‑platforming and marketing optimization are flowing through to profitability. [16]
  • Travel demand breadth: Management and third‑party reporting indicate travel demand remains resilient across income tiers—not just among premium travelers—supporting volumes into the holiday quarter. [17]

What to watch next

  1. Holiday quarter cadence: Can Expedia hit its Q4 guide (revenue +6%–7%; bookings ~+7%) amid a mixed U.S. macro? [18]
  2. B2B pipeline & partner adds: Sustaining ~20%+ B2B growth will be key to the multi‑year margin story. [19]
  3. Regional mix: With Asia room‑nights up 20%+, watch whether international strength offsets any U.S. softness. [20]
  4. Capital returns: Follow‑through on dividend continuity and buybacks after the Q3 $451M repurchase. [21]

This article is for informational purposes and is not investment advice. [22]

Expedia's Hidden Potential?
Watch this video on YouTube.

References

1. www.reuters.com, 2. www.expediagroup.com, 3. s202.q4cdn.com, 4. www.expediagroup.com, 5. www.expediagroup.com, 6. www.reuters.com, 7. www.expediagroup.com, 8. s202.q4cdn.com, 9. www.expediagroup.com, 10. www.expediagroup.com, 11. www.reuters.com, 12. www.investing.com, 13. www.investing.com, 14. www.barrons.com, 15. s202.q4cdn.com, 16. www.expediagroup.com, 17. www.marketwatch.com, 18. www.expediagroup.com, 19. s202.q4cdn.com, 20. www.reuters.com, 21. www.expediagroup.com, 22. www.expediagroup.com

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. VTI vs. VOO on November 7, 2025: Daily Update, Flows & Why Vanguard’s Flagship ETFs Still Dominate With Young Investors
  2. Fluor (FLR) Q3 2025: Adjusted EPS Beats, Guidance Raised; $800M Buyback Target and NuScale Monetization Drive Outlook
  3. Franklin Resources (BEN) Q4 FY2025: Adj. EPS $0.67 Beats, Revenue $2.34B; AUM $1.66T as Ex‑Western Inflows Climb
  4. JFrog (FROG) Soars 20%+ After Q3 Beat: Cloud Revenue Jumps 50%, FY2025 Guidance Raised to $523–$525M

Stock Market Today

  • US stock market today: Futures slip as tech slump deepens; Nasdaq on track for biggest weekly drop since March
    November 7, 2025, 2:14 PM EST. US stocks slipped in morning trade, with major indices on track for their first weekly loss in four weeks as technology shares weighed sentiment. The S&P 500 fell 0.7%, the Dow Jones Industrial Average down 143 points (0.3%), and the Nasdaq Composite down 1.2% as of 9:51 am ET. Big tech led declines: Nvidia off more than 2% with a weekly loss >9%, Oracle down over 3% and near 10% weekly loss, Palantir Technologies tumbling 14% for the week, and Broadcom down 5%. Block sank ~11% after disappointing results; Peloton rose ~6% after earnings beat. All three major indices heading for steep weekly losses; Nasdaq set for worst week since March. International markets weaker on China trade data; economists see rebound after Trump-Xi talks.
  • Wall Street slips, on track for a losing week as investors brace for earnings and data
    November 7, 2025, 2:10 PM EST. Equities slipped on Friday, leaving U.S. stocks on track for a losing week as traders digested new economic data and recalibrated expectations for monetary policy. The major indices gave back gains, with technology shares among the biggest decliners and the S&P 500 drifting lower. Sentiment remained cautious ahead of upcoming earnings reports and central-bank commentary, while a risk-off tone reasserted itself in rate-sensitive sectors. The Nasdaq Composite and Russell 2000 slipped, contrasting with pockets of defensive and value plays that offered modest support. Looking ahead, investors will monitor inflation readings, wage data, and company guidance to gauge whether the weak trend persists into next week.
  • 'Musk is Tesla and Tesla is Musk' - why US investors are happy to pay him $1tn
    November 7, 2025, 2:08 PM EST. Investors are voting with their dollars as Elon Musk's $1 trillion compensation plan for Tesla edges toward approval, potentially rewarding him for lifting the company from roughly $1.4 trillion to $8.5 trillion in market value. Despite controversy around his public persona, Tesla shareholders argue the company's fortunes are inextricably linked to Musk. Shares have climbed nearly two-thirds since May, helped by strong deliveries and tax credits, even as competition from China grows. Analysts note a culture among US investors of backing visionary founders and entrepreneurs, though critics warn of a potential brand crisis. If targets are met, this could become the largest corporate payout in history. The focus remains on execution and how far the stock can rise as Musk's influence stays tied to the brand.
  • Dow Movers: KO Leads as CAT Dips; NVIDIA and McDonald's Move
    November 7, 2025, 2:04 PM EST. Dow movers in early trading show Coca-Cola (KO) leading the session, up about 1.5%. KO is up 12.6% year to date. The day's worst performer among the Dow components is Caterpillar (CAT), down roughly 2.8%, though CAT remains up about 52.7% year to date. Other notable moves include NVIDIA down 2.8% and McDonald's (MCD) up roughly 1.2%. The session reflects a mixed intraday tone for the Dow, with heavyweight names continuing to swing as investors weigh near-term momentum against longer-term gains.
  • COLL June 2026 Options Spotlight: Put at $30 and Covered Call at $45
    November 7, 2025, 2:03 PM EST. Investors in Collegium Pharmaceutical (COLL) got new June 2026 options with 223 days to expiration. YieldBoost flags a $30 put (bid ~ $0.30) and a $45 call (bid ~ $3.60). Selling the $30 put creates an effective cost basis of about $29.70 if assigned, versus the current $42.88 stock price. The strike is roughly 30% out-of-the-money, with an estimated 86% chance the put expires worthless, implying a 1.00% return on cash (about 1.64% annualized). For a covered call on shares bought at $42.88, selling the $45 call could yield about 13.34% total return if called away, excluding dividends. The article notes tracking these odds over time and references the trailing twelve-month history.
BIO-key (BKYI) spikes on major Middle East defense biometric deployment — stock reacts as company expands EMEA footprint [Nov. 7, 2025]
Previous Story

BIO-key (BKYI) spikes on major Middle East defense biometric deployment — stock reacts as company expands EMEA footprint [Nov. 7, 2025]

Conduent (CNDT) Q3 2025: $767M Revenue, 5.2% Adjusted EBITDA Margin; Debt Refi Completed as Company Pushes GenAI Across Offerings
Next Story

Conduent (CNDT) Q3 2025: $767M Revenue, 5.2% Adjusted EBITDA Margin; Debt Refi Completed as Company Pushes GenAI Across Offerings

Related Articles

Go toTop